Maternal treatment with agonistic autoantibodies against type-1 angiotensin II receptor in late pregnancy increases apoptosis of myocardial cells and myocardial susceptibility to ischemia-reperfusion injury in offspring rats

13Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Epidemiological studies have demonstrated that offspring born to mothers preeclampsia (PE) are at increased risk for developing cardiovascular diseases after birth, but the underlying mechanism is unknown. Angiotensin II receptor type 1 autoantibody (AT1-AA), an agonist acting via activation of the AT1 receptor, is believed to be involved in the pathogenesis of both PE and fetal growth restriction. The aim of the present study was to confirm the hypothesis that prenatal AT1-AA exposure increases the heart susceptibility to ischemia/reperfusion injury (IRI) in the offspring in an AT1-AA-induced animal model of PE, and determine whether or not the increase of maternal AT1-AA level is a factor contributing to sustained abnormalities of the heart structure during infancy. The hearts of 45-day-old offspring rats were studied using Langendorff preparation to determine the susceptibility of the heart to IRI. The results showed that the body weight of the maternal rats was not significantly different between the study and control groups, but the body weight of their offspring in AT1-AA group was decreased slightly at day 21 of gestational age, and at day 3 after birth. Although the heart weight index was not significantly affected at all ages examined, AT1-AA significantly increased the size of myocardial cells of the left ventricle (LV) at the age of 45 days. AT1-AA gained access to fetal circulation via the placenta and induced apoptosis of fetal myocardial cells. AT1-AA also significantly delayed recovery from IRI and affected the LV function of 45-day-old offspring. This was associated with a significant increase in IRI-induced LV myocardial infarct size. These results suggest that AT1-AA induced abnormal apoptosis of fetal myocardial cells during the fetal period and increased the cardiac susceptibility to IRI in adult offspring. © 2013 Jin et al.

References Powered by Scopus

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT<inf>1</inf> receptor

742Citations
N/AReaders
Get full text

A mechanistic role for cardiac myocyte apoptosis in heart failure

679Citations
N/AReaders
Get full text

Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice

396Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Prenatal exposure to preeclampsia as an independent risk factor for long-term cardiovascular morbidity of the offspring

96Citations
N/AReaders
Get full text

Animal Models of Preeclampsia: Causes, Consequences, and Interventions

78Citations
N/AReaders
Get full text

Preeclampsia as modulator of offspring health

61Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jin, Z., Zhang, W., Yang, H., Wang, X., Zheng, Y., Zhang, Q., & Zhi, J. (2013). Maternal treatment with agonistic autoantibodies against type-1 angiotensin II receptor in late pregnancy increases apoptosis of myocardial cells and myocardial susceptibility to ischemia-reperfusion injury in offspring rats. PLoS ONE, 8(11). https://doi.org/10.1371/journal.pone.0080709

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

85%

Professor / Associate Prof. 1

8%

Researcher 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

38%

Nursing and Health Professions 3

23%

Agricultural and Biological Sciences 3

23%

Biochemistry, Genetics and Molecular Bi... 2

15%

Save time finding and organizing research with Mendeley

Sign up for free